Osteoporosis Treatment Market 2028 By Drug Type, Route of Administration, Distribution Channel and Geography | The Insight Partners

MARKET OVERVIEW

Osteoporosis is a medical condition that affects people and is characterised by decreased bone density and quality. Furthermore, with this medical condition, the bones become porous, making them more fragile and prone to fractures. The disorder is caused by an excessive amount of the hormone parathyroid. The condition can result in serious fractures, which can be harmful to the patient's health. As a result, the condition requires therapy, which involves the administration of osteoporosis drugs. Some of the drugs for osteoporosis available in the market include, parathyroid hormone therapy, calcitonin, bisphosphonates selective estrogen inhibitors modulator (SERM), and RANK ligand inhibitors. These drugs are administered through various routes in the body such as oral route and intravenous route.

MARKET SCOPE

The "Global Osteoporosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the osteoporosis treatment market with detailed market segmentation by drug type, route of administration and distribution channel. The report provides key statistics on the market status of the leading osteoporosis treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on drug type the market is segmented as, calcitonin, bisphosphonates, selective estrogen receptor modulators (SERMs), rank ligand (RANKL) inhibitor, parathyroid hormone-related protein (PTHrP) analog and others.
  
•   Based on route of administration the market is segmented as, oral, injectable and others.
  
•   Based on distribution channel the market is segmented as, hospitals, retail pharmacies and online pharmacies.
  

MARKET DYNAMICS

Drivers:

•   Increasing prevalence of osteoporosis across the globe.
  
•   Increasing geriatric population across the globe and adoption of sedentary lifestyles.
  
•   Risk factors such as, older age, unhealthy lifestyles, tobacco consumption, alcoholism presence of comorbidities.
  
•   Increasing awareness about osteoporosis treatment and effective management of disease.
  
•   Presence of robust pipeline of therapeutic agents for treatment of osteoporosis.
  

Restraints:

•   However, side effects from prolonged treatment and time consuming product approval procedure are expected to restrain market growth.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The osteoporosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the osteoporosis treatment market in these regions.

IMPACT OF COVID-19 ON OSTEOPOROSIS TREATMENT MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the osteoporosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from osteoporosis treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for osteoporosis treatment in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the osteoporosis treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  Teva Pharmaceutical Industries Ltd.

  Mylan N.V.

  Dr. Reddy's Laboratories Ltd

  Takeda Pharmaceutical Company Limited

  F. Hoffmann-La Roche Ltd

  Radius Health, Inc.

  GlaxoSmithKline plc.

  Novartis AG

  Amgen Inc

  Asahi Kasei Pharma Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.